JPWO2021091846A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021091846A5 JPWO2021091846A5 JP2022526152A JP2022526152A JPWO2021091846A5 JP WO2021091846 A5 JPWO2021091846 A5 JP WO2021091846A5 JP 2022526152 A JP2022526152 A JP 2022526152A JP 2022526152 A JP2022526152 A JP 2022526152A JP WO2021091846 A5 JPWO2021091846 A5 JP WO2021091846A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- mast cell
- mcas
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962930338P | 2019-11-04 | 2019-11-04 | |
| US62/930,338 | 2019-11-04 | ||
| PCT/US2020/058632 WO2021091846A1 (en) | 2019-11-04 | 2020-11-03 | Treatment of mast cell diseases and eosinophilic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023501397A JP2023501397A (ja) | 2023-01-18 |
| JPWO2021091846A5 true JPWO2021091846A5 (de) | 2023-11-13 |
Family
ID=73740487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526152A Withdrawn JP2023501397A (ja) | 2019-11-04 | 2020-11-03 | 肥満細胞疾患および好酸球性障害の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220370465A1 (de) |
| EP (1) | EP4054587A1 (de) |
| JP (1) | JP2023501397A (de) |
| CN (1) | CN114945371A (de) |
| TW (1) | TW202122089A (de) |
| WO (1) | WO2021091846A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3856341T3 (da) * | 2019-04-12 | 2023-12-04 | Blueprint Medicines Corp | Krystallinske former af (s)-1-(4-fluorphenyl)-1-(2-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amin og fremgangsmåder til fremstilling deraf |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2706235C2 (ru) * | 2013-10-17 | 2019-11-15 | Блюпринт Медсинс Корпорейшн | Композиции, пригодные для лечения расстройств, связанных с kit |
| WO2016071511A1 (en) * | 2014-11-07 | 2016-05-12 | Ab Science | Treatment of mast cell activation syndrome (mcas) with masitinib |
-
2020
- 2020-11-03 JP JP2022526152A patent/JP2023501397A/ja not_active Withdrawn
- 2020-11-03 US US17/773,447 patent/US20220370465A1/en not_active Abandoned
- 2020-11-03 CN CN202080091649.2A patent/CN114945371A/zh active Pending
- 2020-11-03 TW TW109138286A patent/TW202122089A/zh unknown
- 2020-11-03 EP EP20820595.5A patent/EP4054587A1/de not_active Withdrawn
- 2020-11-03 WO PCT/US2020/058632 patent/WO2021091846A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9320727B2 (en) | Combinations of SGLT 2 inhibitors and antihypertensive drugs | |
| CN103687593A (zh) | 组织蛋白酶k抑制用于治疗和/或预防肺动脉高压和/或心力衰竭的用途 | |
| CN115361946A (zh) | 治疗α-1抗胰蛋白酶缺乏症的方法 | |
| JPWO2021091846A5 (de) | ||
| KR20140091522A (ko) | 심부전증 또는 신경 손상을 치료하기 위한 인돌릴 및 인돌리닐 하이드록사메이트의 용도 | |
| JP5504263B2 (ja) | 高血圧と代謝症候群の治療に用いられる医薬組成物及びその使用 | |
| AU2019230196A1 (en) | Compositions and methods for treatment of insulin resistance | |
| KR20120083889A (ko) | 당뇨병의 예방을 위한 설폰아마이드 | |
| Pelizzo et al. | Effects of simvastatin on fetal cardiac impairment in the diaphragmatic experimental hernia model | |
| TW202122089A (zh) | 肥大細胞疾病及嗜酸性病症之治療 | |
| JP7508447B2 (ja) | 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸 | |
| US20180092891A1 (en) | Preventing amyloid plaque formation by treating a human subject with a nitroxide | |
| JP2008526945A5 (de) | ||
| Khater et al. | WCN24-2336 BARIATRIC SURGERY AS AN OPTIONAL SECOND LINE TREATMENT FOR PERSISTENT PROTEINURIA IN OBESE NEPHROTIC SYNDROME PATIENT | |
| US20180078538A1 (en) | Method of treating a human subject having a desmosome associated disorder by administering a nitroxide | |
| Imyanitov et al. | 25P Identification of novel kinase-activating fusions in non-small cell lung carcinomas (NSCLCs) | |
| CN106511350A (zh) | 6‑羟基‑7‑芳甲酰基喹啉酮类化合物在治疗溃疡性结肠炎中的应用 | |
| US20200171001A1 (en) | Combination therapy with 2,3-dihydro-isoindole-1-one compounds and methods for treating patients with various mutations | |
| CN106265677B (zh) | 一种防治溃疡性结肠炎的药物组合物及其应用 | |
| Morello et al. | P6263 Phosphoinositide 3-kinase gamma inhibition protects against anthracycline-induced cardiomyopathy by boosting cardiac autophagy | |
| CN1522727A (zh) | 一种治疗前列腺增生的药物及其制备方法 | |
| Lakhoua et al. | Prevalence of diabetes and frequency of cardiovascular risk factors in paramedical and administrative staff of Charles Nicolle hospital | |
| WO2019213302A1 (en) | Treating friedreich's ataxia with dimethyl fumarate | |
| Nozaki et al. | Results of unilateral adrenalectomy in subclinical C ushing's syndrome due to adrenocorticotropic hormone‐independent macronodular adrenal hyperplasia | |
| CN104288764A (zh) | Cd146作为预防和/或治疗缺血性眼部疾病的药物靶点的应用 |